Cassava Sciences Inc (SAVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 128,574 | 121,136 | 201,015 | 233,437 | 93,506 |
| TOTAL | $136,532 | $129,633 | $211,226 | $244,482 | $93,994 |
| Non-Current Assets | |||||
| PPE Net | 20,964 | 21,854 | 22,864 | 20,616 | 11 |
| Intangibles | 37 | 176 | 622 | 1,075 | 0 |
| Other Non-Current Assets | 0 | 0 | 122 | 609 | 295 |
| TOTAL | $21,001 | $22,030 | $23,608 | $22,300 | $306 |
| Total Assets | $157,533 | $151,663 | $234,834 | $266,782 | $94,300 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,654 | 10,573 | 4,017 | 7,126 | 911 |
| Accrued Expenses | 3,797 | 3,237 | 2,450 | 4,680 | 802 |
| Other current liabilities | 299 | 385 | 492 | 631 | 94 |
| TOTAL | $11,750 | $14,195 | $7,063 | $12,534 | $1,865 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 79 | 0 | 232 | 333 | 235 |
| TOTAL | $79 | $N/A | $232 | $333 | $235 |
| Total Liabilities | $11,829 | $14,195 | $7,295 | $12,867 | $2,100 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,308 | 43,225 | 41,736 | 40,017 | 39,898 |
| Common Shares | 48 | 42 | 42 | 40 | 35 |
| Retained earnings | -405,111 | -380,769 | -283,552 | -207,306 | -174,921 |
| TOTAL | $145,704 | $137,468 | $227,539 | $253,915 | $92,200 |
| Total Liabilities And Equity | $157,533 | $151,663 | $234,834 | $266,782 | $94,300 |